Vanguard Group Inc Pyxis Oncology, Inc. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,149,396 shares of PYXS stock, worth $2.24 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,149,396
Previous 2,436,728
11.79%
Holding current value
$2.24 Million
Previous $2.39 Million
0.96%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding PYXS
# of Institutions
74Shares Held
22.9MCall Options Held
0Put Options Held
0-
Laurion Capital Management LP New York, NY3.63MShares$3.77 Million0.07% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.54MShares$3.68 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$2.9 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.5MShares$2.6 Million0.16% of portfolio
-
Palo Alto Investors LP Palo Alto, CA1.04MShares$1.08 Million0.26% of portfolio
About Pyxis Oncology, Inc.
- Ticker PYXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,096,400
- Market Cap $36.5M
- Description
- Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...